{
    "clinical_study": {
        "@rank": "1483", 
        "arm_group": {
            "arm_group_label": "Metal Stent", 
            "arm_group_type": "Experimental", 
            "description": "The WallFlex\u2122 Esophageal Fully Covered Metal Stent (FCMS)is being evaluated for the treatment of refractory benign esophageal strictures caused by caustic ingestion."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to establish clinical proof of concept of temporary indwell  of\n      the WallFlex\u2122 Esophageal Fully Covered Metal Stent (FCMS) for the treatment of refractory\n      benign esophageal strictures caused by caustic ingestion."
        }, 
        "brief_title": "Esophageal Fully Covered Metal Stents in Caustic Strictures Study", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Refractory Benign Esophageal Strictures Caused by Caustic Ingestion", 
        "condition_browse": {
            "mesh_term": [
                "Esophageal Stenosis", 
                "Constriction, Pathologic"
            ]
        }, 
        "detailed_description": {
            "textblock": "The purpose of this study is to establish clinical proof of concept of temporary indwell  of\n      the WallFlex\u2122 Esophageal Fully Covered Metal Stent (FCMS) for the treatment of refractory\n      benign esophageal strictures caused by caustic ingestion. Also to collect data in support of\n      a hypothesis required to prospectively document the safety and effectiveness of temporary\n      indwell of the WallFlex\u2122 Esophageal Fully Covered Metal Stent (FCMS) compared to repeated\n      Bougie Dilation for the treatment of refractory benign esophageal strictures caused by\n      caustic ingestion."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Availability of medical history pertaining to dysphagia score prior to and during the\n             preceding SECSER.\n\n          2. Availability of patient history pertaining to weight prior to and at completion of\n             SECSER.\n\n          3. Benign esophageal stricture caused by caustic ingestion 12 or more weeks prior to\n             enrollment.\n\n          4. Single esophageal stricture or multiple esophageal stricture over a length < 6 cm.\n\n          5. Having completed the SECSER consisting of 3 dilations intended to reach 15 mm each,\n             separated by 2 weeks, followed by 3 dilations intended to reach 15 mm each with\n             steroid injections, separated by 2 weeks.  The dilations may be performed using\n             Bougie or balloon dilation at the discretion of the investigator.\n\n          6. Refractory stricture defined as recurrence of stricture with associated dysphagia\n             within 6 months after completion of SECSER.\n\n          7. Dysphagia score of 2 (ability to swallow semi-solid foods), 3 (ability to swallow\n             liquids only) or 4 (unable to swallow liquids) at baseline.\n\n          8. Unable to pass a standard endoscope (approximately 9.8 mm diameter).\n\n          9. Age 18 years or older.\n\n         10. Willing and able to comply with the study procedures and provide written informed\n             consent to participate in the study.\n\n        Exclusion Criteria:\n\n          1. Stricture within 2 cm of the upper esophageal sphincter.\n\n          2. Concomitant Esophageal ulcerations.\n\n          3. Prior esophageal stent placements.\n\n          4. Concurrent gastric and/or duodenal obstruction.\n\n          5. Patients with prior full or partial gastrectomy.\n\n          6. Sensitivity to any components of the stent or delivery system.\n\n          7. Concurrent medical condition that would affect the investigator's ability to evaluate\n             the patient's condition or could compromise patient safety.\n\n          8. Participation in a clinical trial evaluating an investigational device within 3\n             months prior to enrollment in this study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01899300", 
            "org_study_id": "90871111"
        }, 
        "intervention": {
            "arm_group_label": "Metal Stent", 
            "intervention_name": "Metal Stent (WallFlex\u2122 Esophageal RX)", 
            "intervention_type": "Device", 
            "other_name": "WallFlex\u2122 Esophageal RX Fully Covered Stent"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "Refractory Benign Esophageal Strictures caused by Caustic Ingestion", 
        "lastchanged_date": "February 4, 2014", 
        "location": [
            {
                "contact": {
                    "email": "dr_kochhar@hotmail.com", 
                    "last_name": "Rakesh Kochhar", 
                    "phone": "0172756608"
                }, 
                "facility": {
                    "address": {
                        "city": "Chandigarh", 
                        "country": "India", 
                        "zip": "160012"
                    }, 
                    "name": "Postgraduate Institute of Medical Education and Research"
                }, 
                "investigator": {
                    "last_name": "Rakesh Kochhar, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "drrajeshgupta98@gmail.com", 
                    "last_name": "Rajesh Gupta, MD", 
                    "phone": "4023378888"
                }, 
                "facility": {
                    "address": {
                        "city": "Hyderabad", 
                        "country": "India", 
                        "zip": "500082"
                    }, 
                    "name": "Asian Institute of Gastroenterology"
                }, 
                "investigator": {
                    "last_name": "Rajesh Gupta, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "India"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Multi-Center, Prospective, Evaluation of the Use of a Fully Covered Metal Stent (FCMS) for the Treatment of Refractory Benign Esophageal Strictures Caused by Caustic Ingestion", 
        "overall_contact": {
            "email": "pooja.goswamy@bsci.com", 
            "last_name": "Pooja Goswamy", 
            "phone": "508-683-4335"
        }, 
        "overall_contact_backup": {
            "email": "andrea.burbage@bsci.com", 
            "last_name": "Andrea Burbage", 
            "phone": "508-683-4387"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "India: DCGI", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Patient ability to tolerate the completion of planned stent indwell and ability to adequately sustain nutrition defined as absence of dysphagia-related reintervention for 6 months after the stent is removed.", 
            "measure": "Clinical success consisting of stent tolerability and adequate ability to sustain nutrition to 6 months after stent removal.", 
            "safety_issue": "No", 
            "time_frame": "9 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01899300"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Technical stent placement success defined as the ability to deploy the stent in satisfactory position across the stricture.", 
                "safety_issue": "No", 
                "time_frame": "9 months"
            }, 
            {
                "measure": "Stent removal success defined by the ability to remove the stent endoscopically without stent removal related complications.", 
                "safety_issue": "No", 
                "time_frame": "9 months"
            }, 
            {
                "measure": "Stent tolerability defined as completion of planned stent indwell.", 
                "safety_issue": "No", 
                "time_frame": "9 months"
            }, 
            {
                "measure": "Patient's Report on Pain compared to Baseline: Day 2, week 1, week 2, and thereafter every 2 weeks until stent removal.", 
                "safety_issue": "No", 
                "time_frame": "9 months"
            }, 
            {
                "measure": "Change of pain medication intake from Baseline:  Day 2, week 1, week 2, and thereafter every 2 weeks until stent removal.", 
                "safety_issue": "No", 
                "time_frame": "9 months"
            }, 
            {
                "measure": "Improvement of dysphagia score compared to Baseline:  Day 2, week 1, week 2, and thereafter every 2 weeks until end of study.", 
                "safety_issue": "No", 
                "time_frame": "9 months"
            }, 
            {
                "measure": "Dysphagia score during stent treatment compared to dysphagia score during preceding Standardized Esophageal Caustic Stricture Endoscopic Treatment Regimen (SECSER).", 
                "safety_issue": "No", 
                "time_frame": "9 months"
            }, 
            {
                "measure": "Quality Of Life (QOL) Improvement compared to Baseline:  Day 2, week 1, week 2, and thereafter every 2 weeks until end of study.", 
                "safety_issue": "Yes", 
                "time_frame": "9 months"
            }, 
            {
                "measure": "Occurrence and severity of adverse events related to the stent and/or the stent placement or stent removal procedure and of all serious adverse events throughout the duration of the study.", 
                "safety_issue": "No", 
                "time_frame": "9 months"
            }, 
            {
                "measure": "Time to recurrence of stricture, defined as inability of a normal diameter gastroscope (9.8 mm) to pass the stricture.", 
                "safety_issue": "No", 
                "time_frame": "9 months"
            }, 
            {
                "measure": "Incidence of stent migration with or without related Adverse Events (AE).", 
                "safety_issue": "No", 
                "time_frame": "9 month"
            }, 
            {
                "description": "Number of reinterventions from enrollment to end of study, excluding the stent placement and stent removal procedures.", 
                "measure": "Health Economic Endpoint", 
                "safety_issue": "Yes", 
                "time_frame": "9 months"
            }, 
            {
                "measure": "Improvement in Patient Weight compared to Baseline:  Day 2, week 1, week 2, and thereafter every 2 weeks until end of study.", 
                "safety_issue": "No", 
                "time_frame": "9 months"
            }, 
            {
                "measure": "Weight gain during stent treatment compared to weight gain during preceding SECSER.", 
                "safety_issue": "No", 
                "time_frame": "9 months"
            }
        ], 
        "source": "Boston Scientific Corporation", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Boston Scientific Corporation", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}